Related Experiment Video
Updated: Dec 25, 2025

17:28
Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
13.0K
Introducing the concept of virtual control groups into preclinical toxicology testing
Thomas Steger-Hartmann1, Annika Kreuchwig1, Lea Vaas1
1Bayer AG, Pharmaceuticals, Investigational Toxicology, Berlin, Germany.
ALTEX
|April 4, 2020
Summary
Virtual control groups (VCGs) from historical animal data could reduce animal use by 25% in toxicity studies. This approach requires robust data sharing and statistical validation for regulatory applications.
Area of Science:
- Toxicology
- Preclinical research
- Data science
Background:
- Sharing legacy data from in vivo toxicity studies allows analysis of control group variability.
- Historical control data can form a repository for constructing virtual control groups (VCGs).
- VCGs are established in clinical trials but novel for regulatory animal studies.
Purpose of the Study:
- To explore the potential of using virtual control groups (VCGs) in regulatory animal toxicity studies.
- To assess the feasibility of reducing animal use through VCGs.
- To lay the foundation for data sharing and statistical evaluation of VCGs.
Main Methods:
- Collecting and characterizing control group data from subacute (4-week) GLP studies with Wistar rats.
- Sharing control group data among participating companies to investigate cross-company variability.
- Analyzing a set of studies to compare outcomes using VCG data versus real control groups.
Main Results:
- The use of VCGs has the potential to reduce animal use by 25%.
- Prerequisites include large, well-structured control datasets and thorough statistical evaluations.
- Initiatives like eTOX and eTRANSAFE are establishing the foundation for data sharing.
Conclusions:
- VCGs offer a promising approach to reduce animal use in regulatory toxicity studies.
- Successful implementation requires significant advancements in data sharing infrastructure and statistical methodologies.
- Further validation is needed to confirm the impact of VCGs on study outcomes.
Related Concept Videos
Preclinical Development: Overview
5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Controls in Experiments
14.6K
When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
14.6K
In Vitro Drug Release Testing: Overview, Development and Validation
227
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
227

